Target intelligence / Profile preview

Immunologic Cytotoxicity

Molecular classification
Biological Process
01

Overview

Immunologic cytotoxicity refers to the destruction of target cells by immunologically active effector cells. This process is a fundamental mechanism of the immune system, enabling it to eliminate infected, transformed (cancerous), or otherwise abnormal cells. The destruction can be mediated directly by sensitized T-lymphocytes (cytotoxic T cells), by lymphoid or myeloid killer cells (such as natural killer [NK] cells), or indirectly via cytotoxic antibodies, factors released by lymphoid cells, or complement proteins. Mechanisms include CTL-mediated killing (perforin/granzymes, Fas ligand), NK cell-mediated cytotoxicity, and antibody-dependent cellular cytotoxicity (ADCC).

Other names
Immune-mediated cytolysisImmune-mediated killing
02

Biological functions

Cell deathImmune responseDefense against viral infectionsElimination of cancerous/transformed host cellsRemoval of pathogen-infected host tissues
03

Disease associations

CancerViral InfectionsAutoimmune Diseases
04

Safety considerations

Off-target cytotoxicityCytokine release syndromeAutoimmunity

Beyond the preview

Go deeper on Immunologic Cytotoxicity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunologic Cytotoxicity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call